CNS vs GNW

CNS exhibits a stable financial foundation with a Piotroski F-Score of 5/9 and very low debt (D/E 0.22), but it is fundamentally overvalued. The current price of $67.71 trades at a significant premium to both the Graham Number ($27.35) and the growth-based Intrinsic Value ($50.59). This valuation gap is compounded by a bearish technical trend (0/100), insider selling, and a dangerously high dividend payout ratio of 83.77%. Recent earnings performance is lackluster, with only one beat in the last four quarters.

Genworth Financial presents a classic value trap profile, characterized by a stable Piotroski F-Score of 4/9 and a significant discount to book value (P/B 0.40). While the Graham Number of $16.47 suggests substantial defensive value, this is heavily offset by an intrinsic value of $3.78 and a severe collapse in earnings growth (-63.6% YoY). The company maintains a strong liquidity position with a current ratio of 10.49, but stagnant revenue growth (0.10%) and thin profit margins indicate a lack of operational momentum. The divergence between the low P/B and the crashing EPS suggests the market is pricing in long-term structural headwinds despite recent short-term price gains.